Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.
about
Role of Receptor Tyrosine Kinase Signaling in Renal FibrosisEGFR signaling in renal fibrosisPodocyte-Specific Deletion of Murine CXADR Does Not Impair Podocyte Development, Function or Stress ResponseEpidermal growth factor: a new therapeutic target in glomerular disease.What is new in the management of rapidly progressive glomerulonephritis?Lutheran/basal cell adhesion molecule accelerates progression of crescentic glomerulonephritis in mice.Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond.Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular SystemErlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats.Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in ratsEndothelin and the podocyteEGF receptor deletion in podocytes attenuates diabetic nephropathy.p47(phox) contributes to albuminuria and kidney fibrosis in mice.Gq signaling causes glomerular injury by activating TRPC6.Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal DiseaseAbsence of nicotinic acetylcholine receptor α7 subunit amplifies inflammation and accelerates onset of fibrosis: an inflammatory kidney model.The role of thrombomodulin lectin-like domain in inflammationEndothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.Sex difference in EGFR pathways in mouse kidney-potential impact on the immune systemRole of epidermal growth factor receptor in acute and chronic kidney injury.Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GNPodocyte p53 Limits the Severity of Experimental Alport Syndrome.Combined Effects of PPAR γ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells.Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis.Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2)Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension.MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy.Epidermal growth factors in the kidney and relationship to hypertension.Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progressionLow nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.ADAM17 substrate release in proximal tubule drives kidney fibrosisMesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor.Autoantibodies to hLAMP-2 in ANCA-negative pauci-immune focal necrotizing GNIntraglomerular crosstalk elaborately regulates podocyte injury and repair in diabetic patients: insights from a 3D multiscale modeling study.Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosisEpidermal growth factor receptor mediates injury in rapidly progressive glomerular disease.Danger control programs cause tissue injury and remodeling.Signal transduction in podocytes--spotlight on receptor tyrosine kinases.Immunopathology of lupus nephritis.The emergence of the glomerular parietal epithelial cell.
P2860
Q26743407-61CE6C6A-0697-4270-BD98-6BC03C1513FAQ26796628-12CC9AE6-0661-4470-AC4F-73D5E0A6E4FFQ27304723-9AD427A2-9B86-4ADE-BFD5-102E2AEB954AQ27686898-C088451D-1BA1-4A3F-8DDF-639FC813D683Q28259540-599669EB-2516-47E6-ADAC-BC571CDB6915Q33561662-3F09B3CE-65B4-47C3-B1D4-32D3AE0D7D68Q33620537-B5719633-EC15-4CFD-AEB3-A3206D88A173Q33814199-F54E4570-7A7E-493B-BCF1-C85018965CD3Q34563432-BD12E968-FAB6-4F43-ABA4-6F027C2150FAQ35413351-AEA160B7-5EE4-4CDA-A8F6-A15971FD640DQ35452282-3E2BAEBB-FB88-4C49-9079-87BEB7883B00Q35550573-DFC0B0F5-2C18-4C94-83D6-A31D35C9BDE4Q35587361-63A736F5-1DEE-4FF3-B309-1AED51147F33Q35719874-B0EB1A1A-C879-4397-93D8-EFFC2120783CQ35790512-D3336FBB-469B-41C2-BED0-1F6086BE07AEQ35879006-8AD06C1B-FDCE-42B8-A5B8-3A2B678C5230Q35927779-ED68F46C-2412-4439-8D4C-486B2420DB9DQ36111664-F8F24795-5DE0-4704-86CE-54A19D2F2BF4Q36202764-F248BAF1-1E42-4022-9D6D-5B6224452EA0Q36224457-75B3038A-7AAC-4362-BD95-2D8EB6C0A3ADQ36417899-AA051CC3-A0BC-451D-AAAF-D474EB943E88Q36417903-BE81119C-1966-4030-B009-6023BA9F377DQ36682692-A549461A-2726-4692-8AC6-40C205478193Q36763871-71260DD6-B1C7-4380-A4AB-DD14E21625D6Q36947844-A4C6D169-03D7-4413-A6D6-B1D8EA56A2B0Q36977357-94984F75-C67A-4966-A26D-788075B53F00Q36980645-674F8542-5ED9-492F-8298-F2067211E2C2Q37051477-91F131D2-249B-41FE-A49A-43AA5BE5A351Q37200899-F6FB1780-AC05-4FD8-8CDB-895EC0996D96Q37228204-3A21C49C-F964-4CDA-B8B0-80916806F918Q37262336-B566C16B-D7CE-495C-8B7E-02733380ABEDQ37376894-9B258DBE-5A3E-4CD9-88C3-CE4B7955B4CDQ37604720-6C4F0CE6-22A7-4556-A1BE-9CCF89EB615DQ37687354-99BFFA75-3693-4D7C-B6FE-F8EF5A43B1C5Q37733555-5541545E-F905-406F-9ACC-89C12E93C442Q37996877-3813FB6E-DCE0-4A10-9C77-D75AA790E6E0Q38113929-140535E0-9BE4-4151-B447-3110E3E04FB4Q38176169-20F989CC-0028-453D-B0AF-4FD8B3DDD4F0Q38176819-2523510F-421C-4389-A9E9-1E626B376F72Q38182323-B65C1DE8-A324-448F-8802-179F205F9A92
P2860
Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Epidermal growth factor recept ...... crescentic glomerulonephritis.
@ast
Epidermal growth factor recept ...... crescentic glomerulonephritis.
@en
type
label
Epidermal growth factor recept ...... crescentic glomerulonephritis.
@ast
Epidermal growth factor recept ...... crescentic glomerulonephritis.
@en
prefLabel
Epidermal growth factor recept ...... crescentic glomerulonephritis.
@ast
Epidermal growth factor recept ...... crescentic glomerulonephritis.
@en
P2093
P2860
P50
P356
P1433
P1476
Epidermal growth factor recept ...... crescentic glomerulonephritis.
@en
P2093
Anita Rodenas
Ariane Galaup
Cécile Fligny
Elisabeth Rumpel
Eric Schordan
Guillaume Bollée
Ibrahim Casal
Jean-Claude Dussaule
Laurent Mesnard
Marine Milon
P2860
P2888
P304
P356
10.1038/NM.2491
P407
P50
P577
2011-09-25T00:00:00Z
P5875
P6179
1012445410